Guide

21 CFR 111 Subpart E Readiness: Component Identity Testing That Survives Inspection

FDA-483 enforcement data for dietary supplement plants puts component identity testing under 21 CFR 111.75 at the top of the citation list, year after year. The regulation reads simply: before using a component that is a dietary ingredient, the manufacturer must conduct at least one appropriate test or examination to verify identity. In practice the rule has crushed a generation of supplement plants that relied on supplier certificates of analysis — because the qualified-supplier exemption under 21 CFR 111.75(a)(2) is narrow, paperwork-intensive, and rarely survives FDA inspection. This guide maps the working interpretation of Subpart E identity testing and the lab, method and supplier evidence V5 carries to keep it inspection-ready.

Start free trial Free trial, no credit card, onboard in days, not months.

What 21 CFR 111.75 actually requires

21 CFR 111.75(a)(1) requires the manufacturer to conduct at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, before using the component. 21 CFR 111.75(a)(2) allows the manufacturer to rely on a supplier's certificate of analysis only if (i) the supplier is qualified through a documented process, (ii) the manufacturer periodically confirms the supplier's COA is reliable through its own testing, and (iii) the manufacturer documents both. The two exemption requirements are why almost no plant has a defensible Subpart E exemption — periodic confirmation is itself in-house testing, so the operational saving is small relative to the regulatory risk.

Test method selection: what "appropriate" means in practice

FDA does not mandate a specific method but expects "appropriate" — meaning a method validated to distinguish the dietary ingredient from likely adulterants, at the relevant level of resolution. For synthetic chemicals: HPLC, UV/Vis or IR is generally sufficient. For botanicals: FTIR is the working baseline, HPTLC is the step up for closely-related species, DNA barcoding is the resolver for difficult cases (e.g. ginseng species, echinacea species). For minerals: AA or ICP. The method choice must be documented and validated to ICH Q2 or USP <1225> equivalent standards, with validation evidence on file.

Botanical identity: the highest-risk subcategory

Botanical identity is the single most-cited Subpart E gap. The 2015 New York Attorney General investigation of national-retailer herbal supplements (where DNA barcoding suggested up to 79% of products contained none of the labelled botanical) put botanical adulteration on the public record and accelerated FDA enforcement. The working defence is layered identification — macroscopic and organoleptic for the raw material, chromatographic fingerprint (HPTLC or HPLC) for the marker compounds, DNA barcoding for species-level confirmation on high-risk botanicals. Supplier COAs alone are insufficient because botanical mis-identification at the source is common.

Supplier qualification: the 111.75(a)(2) exemption that almost nobody achieves

The qualified-supplier exemption at 21 CFR 111.75(a)(2) requires (a) a documented qualification process for the supplier, (b) periodic confirmation of the supplier's COA reliability through in-house testing, and (c) records of both. FDA's working interpretation is that "periodic" means roughly one in five to ten lots, not one a year. The exemption is most useful for high-volume commodity ingredients where the supplier is large, validated, and stable — and even there it is fragile to supplier changes. For most plants the prudent path is in-house testing on every lot, supplier qualification as a secondary control.

A 45-day Subpart E readiness path

Days 1–10: ingredient-by-ingredient mapping — every dietary ingredient SKU, its current identity test method, validation evidence currency, analyst qualification. Days 11–20: method-validation gap closure — any method without ICH Q2 / USP <1225> equivalent evidence is re-validated. Days 21–30: botanical re-qualification — high-risk botanicals reviewed for layered identification adequacy. Days 31–40: receiving workflow rebuild — quarantine hold, identity test, supplier-COA cross-check, release authority. Days 41–45: mock inspection on Subpart E records.

Standards covered in this guide

Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.

21 CFR 111

The FDA cGMP for dietary supplements — identity testing on every incoming component, MMR/BPR, quality unit sign-off on every batch.

ICH Q2

International standard for proving an analytical method does what it claims — specificity, accuracy, precision, linearity, range, LOD, LOQ, robustness.

Where this lives in V5 Ultimate

The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.

Modules that do the work

Subpart E identity workflow

Quarantine-until-tested at the system level.

Validated-method library

ICH Q2 / USP <1225> evidence per ingredient.

Supplier qualification

111.75(a)(2) dossier with expiry tracking.

Industries this hits hardest

Dietary supplements

Frequently asked

Can we ever skip identity testing on a dietary ingredient?

Only under 21 CFR 111.75(a)(2) with a qualified supplier plus periodic confirmation testing. The operational saving is small because periodic confirmation is itself in-house testing, and FDA inspects the exemption tightly. Almost all plants run identity testing on every lot.

Is FTIR enough for botanical identity?

For most well-characterised botanicals FTIR is sufficient. For closely-related species (echinacea purpurea vs angustifolia, panax ginseng vs quinquefolius) or high-risk adulteration targets HPTLC and DNA barcoding are expected as layered controls. The method choice must be validated for the specific risk.

Does identity testing apply to excipients and other non-dietary components?

21 CFR 111.75 covers components that are dietary ingredients. Other components (excipients, processing aids) fall under 21 CFR 111.75(b) which requires verification of identity per the specification — typically by COA review for low-risk excipients, by in-house testing for high-risk ones.

How do we handle a botanical with no validated reference standard?

Use a documented authenticated reference material — typically a herbarium-voucher specimen, a USP or NIST reference material if available, or a supplier-provided characterised reference with documented chain of custody. The reference material is itself a controlled document under 21 CFR 111.

See it on your shop floor.

Free trial, no credit card, onboard in days, not months.

Start free trial See pricing →Browse all resources →